IBRN: ISHARES NEUROSCIENCE AND HEALTHCARE ETF
ETF Education Report: iShares Neuroscience and Healthcare ETF (IBRN)
What this ETF is trying to do
The iShares Neuroscience and Healthcare ETF (IBRN) focuses on companies involved in neuroscience and healthcare. It holds a variety of different stocks within this specific medical field. According to the data, the fund holds 94 total companies.
What the numbers show
When looking at how this ETF has performed, it is important to look at two different types of returns: price return and total return. Price return only tracks how the share price changes. Total return includes both the price change and any cash distributions (dividends) paid out.
• Year-to-Date (YTD): The YTD price return is approximately -0.86%. The YTD total return is also approximately -0.86%.
• One Year: The one-year price return was approximately 15.34%. However, the one-year total return was higher at approximately 16.49%.
• Three Years: The three-year price return was approximately 51.42%. The three-year total return was approximately 53.56%.
To give you an idea of the price movement, the current price is $32.04. The estimated price from roughly one year ago was approximately $27.78.
Income and distribution explanation
This ETF provides some cash income through distributions. The distribution yield is approximately 0.99%. This number describes the cash paid out relative to the ETF's price. It is important to remember that a distribution yield is not the same as total return.
The data shows the distributions are "irregular," meaning they do not happen on a set schedule. In the last 12 months, there was one payout.
NAV erosion explanation
"NAV erosion" is a term used to describe when the value of the underlying assets in a fund decreases significantly over time. Some investors worry about this because they want their original investment to stay stable.
For IBRN, the erosion-risk score is 100, and the label states "No price erosion detected." The erosion severity is rated as "good," and there is no severe erosion-risk flag.
Top Holdings
The following are the top holdings in this ETF. Please note that this is a partial list of the largest companies held:
• Edwise Therapeutics Inc (4.47%)
• Biogen Inc (4.42%)
• PTC Therapeutics Inc (4.12%)
• Acadia Pharmaceuticals Inc (4.08%)
• Alkermes PLC (4.06%)
• Argenx SE ADR (4.04%)
• Scholar Rock Holding Corp (4.00%)
• Neurocrine Biosciences Inc (3.96%)
• Diantus Therapeutics Inc (3.93%)
• Prax (3.69%)
Pros
• The ETF has shown positive price and total returns over the one-year and three-year periods.
• The erosion-risk measurements suggest no significant price erosion has been detected.
Cons
• The year-to-date (YTD) performance has been slightly negative.
• Distributions are irregular and less frequent.
Beginner takeaway
When studying an ETF like IBRN, always look at the difference between price return and total return. Total return gives a fuller picture because it includes the cash paid out to investors. Also, while this fund pays a distribution yield, high yields alone do not tell the whole story of how an investment is performing.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | EDGEWISE THERAPEUTICS INC | EWTX | 4.47% |
| 2 | BIOGEN INC | BIIB | 4.42% |
| 3 | PTC THERAPEUTICS INC | PTCT | 4.12% |
| 4 | ACADIA PHARMACEUTICALS INC | ACAD | 4.08% |
| 5 | ALKERMES PLC | ALKS | 4.06% |
| 6 | ARGENX SE ADR | ARGX | 4.04% |
| 7 | SCHOLAR ROCK HOLDING CORP | SRRK | 4.00% |
| 8 | NEUROCRINE BIOSCIENCES INC | NBIX | 3.96% |
| 9 | DIANTHUS THERAPEUTICS INC | DNTH | 3.93% |
| 10 | n/a | PRAX | 3.69% |